Key Biologics LLC and Blood Centers of America (BCA) announced an agreement to formalize their existing business relationship and to work collectively to broaden support for cell therapy and regenerative medicine.    The agreement will enable deeper support of joint research and product development and provide valuable expertise needed for commercial therapies. Working together, the organizations will focus on removing barriers to the supply of critical raw materials needed for pre-clini...